Charlie Hatton
- Hematology top 5%
- Acute Myeloid Leukemia Research 8
- Multiple Myeloma Research and Treatments 4
- Molecular Biology top 10%
- Protein Degradation and Inhibitors 11
- Histone Deacetylase Inhibitors Research 5
- Genomics and Chromatin Dynamics 5
- Epigenetics and DNA Methylation 3
- Melanoma and MAPK Pathways 2
- Oncology top 10%
- Pathology and Forensic Medicine top 10%
-
- Cutaneous lymphoproliferative disorders research 1
- Co-authors
- Laura E. MacConaillMaria B. KarpovaPatrick A. OberholzerMarie ZipserLevi A. GarrawayReinhard DummerW. Marston LinehanJessica Kim
- Cited by
- HematologyMolecular BiologyOncology
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Charlie Hatton
20 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 81
- Hematology 323
- Molecular Biology 976
- Oncology 348
- Pathology and Forensic Medicine 138
- Cancer Research 93
Countries citing papers authored by Charlie Hatton
This map shows the geographic impact of Charlie Hatton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlie Hatton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlie Hatton more than expected).
Fields of papers citing papers by Charlie Hatton
This network shows the impact of papers produced by Charlie Hatton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlie Hatton. The network helps show where Charlie Hatton may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charlie Hatton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 41 | |
| 7 | 2021 | 82 | |
| 8 | 2021 | 2 | |
| 9 | 2020 | 152 | |
| 10 | 2018 | 11 | |
| 11 | 2016 | 23 | |
| 12 | 2016 | 70 | |
| 13 | 2016 | 84 | |
| 14 | 2016 | 85 | |
| 15 | 2012 | 2 | |
| 16 | 2011 | 60 | |
| 17 | 2009 | 482 | |
| 18 | 2004 | 8 | |
| 19 | Continuing medical education on the World Wide Web (WWW). Interactive pathology case studies on the Internet. | 1997 | 30 |
| 20 | 1967 | 8 |
About Charlie Hatton
Charlie Hatton is a scholar working on Hematology, Molecular Biology and Cancer Research, having authored 21 papers that have together received 1.2k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (11 papers), Acute Myeloid Leukemia Research (8 papers), Histone Deacetylase Inhibitors Research (5 papers), Genomics and Chromatin Dynamics (5 papers), Multiple Myeloma Research and Treatments (4 papers), Epigenetics and DNA Methylation (3 papers), Melanoma and MAPK Pathways (2 papers) and Cutaneous lymphoproliferative disorders research (1 paper). The work is most often cited by research in Hematology (323 citations), Molecular Biology (976 citations) and Oncology (348 citations). Charlie Hatton has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Laura E. MacConaill, Maria B. Karpova, Patrick A. Oberholzer, Marie Zipser, Levi A. Garraway, Reinhard Dummer, W. Marston Linehan, Jessica Kim, Jianming Zhang and Rajiv Chopra. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.